For the Culture By The Culture. ISSN: 3064-9331.
Cannabis and mental health risks are often overstated in public debate. Research shows heavy use and high THC exposure can increase psychosis risk in vulnerable individuals, but widespread claims of a mental health crisis lack strong evidence. This piece examines the data, separates correlation from causation, and breaks down what cannabis users need to know.
A new cannabis study claims marijuana does nothing for anxiety, depression, or PTSD. The reality is far more complicated. Decades of federal restrictions, limited research access, and synthetic substitutes have shaped the science. This breakdown exposes how incomplete data and selective interpretation continue to drive misleading headlines about cannabis and mental health.
A McMaster-led analysis of two Canadian mental health surveys is getting recycled as a weed panic story, even though the design can only show association. This piece breaks down what the data can actually support, what it cannot prove, and how headlines turn survey correlations into causal claims that fuel stigma, bad policy, and lazy coverage.
Actor David Krumholtz’s experience with Cannabinoid Hyperemesis Syndrome sparked a backlash that reveals a deeper problem in cannabis culture. This piece examines how rare conditions get weaponized, why defensive reactions backfire, and how patients, veterans, and families are erased when nuance collapses on both sides of the cannabis debate.
Federal officials claim cannabis is moving forward, but Schedule III changes nothing that matters. This investigation breaks down what rescheduling actually does, what it deliberately avoids, and why prohibition logic remains intact. Arrests continue. Markets remain conflicted. Reform language replaces reform action. The system shifts labels while preserving control.
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.
